Docosahexaenoic Acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status

Nutrition and Cancer

Volumn 58, Issue 2, 2007, Pages 178-187

  Kato, Taeko ^a   Kolenic, Nicole ^a   Pardini, Ronald S ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERVONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; MENHADEN OIL; POLYUNSATURATED FATTY ACID; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; CORN; DIET; DIETARY INTAKE; GENE MUTATION; LIPID DIET; MOUSE; NONHUMAN;

CHRYSOPHYCEAE; MUS; ZEA MAYS;

EID: 34548262681     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701328362     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al.: Cancer statistics, 2006. CA Cancer J Clin 56(2), 106-130, 2006.
2. Wynder EL, Reddy BS, and Weisburger JH: Environmental dietary factors in colorectal cancer. Some unresolved issues. Cancer 70, 1222-1228, 1992.
3. Bang HO, Dyerberg J, and Hjoorne N: The composition of food consumed by Greenland Eskimos. Acta Med Scand 200, 69-73, 1976.
4. Blot WJ, et al.: Cancer mortality among Alaskan natives, 1960-69. J Natl Cancer Inst 55, 547-554, 1975.
5. Caygill CP, Charlett A, and Hill MJ: Fat, fish, fish oil and cancer. Br J Cancer 74, 159-164, 1996.
6. Willett WC, et al.: Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 323, 1664-1672, 1990.
7. Singh J, Hamid R, and Reddy BS: Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res 57, 253-258, 1997.
8. Connolly JM, Gilhooly EM, and Rose DP: Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr Cancer 35, 44-49, 1999.
9. Kato T, et al.: Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett 187, 169-177, 2002.
10. Hainaut P, et al.: IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res 26, 205-213, 1998.
11. O'Connor PM, et al.: Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res 57, 4285-4300, 1997.
12. Sidransky D and Hollstein M: Clinical implications of the p53 gene. Annu Rev Med 47, 285-301, 1996.
13. Moll UM, Riou G, and Levine AJ: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89, 7262-7266, 1992.
14. Prosser J, et al.: Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene 5, 1573-1579, 1990.
15. Noguchi P, et al.: Characterization of the WIDR: a human colon carcinoma cell line. In Vitro 15, 401-408, 1979.
16. Chen TR, et al.: WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. Cancer Genet Cytogenet 27, 125-134, 1987.
17. Fogh J and Trempe G: New human tumor cell lines. In: Human Tumor Cells In Vitro, J Fogh (ed.). New York: Plenum Press, 1975, pp. 115-159.
18. Tamura T, et al.: Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene 11, 1939-1946, 1995.
19. Semple TU, et al.: Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res 38, 1345-1355, 1978.
20. Borgeson CE, et al.: Effects of dietary fish oil on human mammary carcinoma and on lipid-metabolizing enzymes. Lipids 24, 290-295, 1989.
21. Ho YS, Wang YJ, and Lin JK: Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinog 16, 20-31, 1996.
22. Ho YS, et al.: Suppression of nitric oxide-induced apoptosis by N-acetyl-L-cysteine through modulation of glutathione, bcl-2, and bax protein levels. Mol Carcinog 19, 101-113, 1997.
23. Vousden KH: p53: death star. Cell 103, 691-694, 2000.
24. Calviello G, et al.: n-3 PUFAs reduce VEGF expression in human colon can6cer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1 alpha induction pathway. Carcinogenesis 25, 2303-2310, 2004.
25. Nkondjock A, et al.: Specific fatty acids and human colorectal cancer: an overview. Cancer Detect Prev 27, 55-66, 2003.
26. Rose DP and Connolly JM: Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 83, 217-244, 1999.
27. Ryan KM and Vousden KH: Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol Cell Biol 18, 3692-3698, 1998.
28. Ross JA, et al.: Eicosapentaenoic acid perturbs signalling via the NFkappaB transcriptional pathway in pancreatic tumour cells. Int J Oncol 23, 1733-1738, 2003.
29. Hawkins RA, Sangster K, and Arends MJ: Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 185, 61-70, 1998.
30. Lai PB, et al.: Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br J Cancer 74, 1375-1383, 1996.
31. Heimli H, et al.: Eicosapentaenoic acid promotes apoptosis in Ramos cells via activation of caspase-3 and -9. Lipids 37, 797-802, 2002.
32. Arita K, et al.: Mechanism of apoptosis in HL-60 cells induced by n-3 and n-6 polyunsaturated fatty acids. Biochem Pharmacol 62, 821-828, 2001.
33. Chiu LC, Ooi VE, and Wan JM: Eicosapentaenoic acid modulates cyclin expression and arrests cell cycle progression in human leukemic K-562 cells. Int J Oncol 19, 845-849, 2001.
34. Clarke RG, et al.: Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29. Lipids 34, 1287-1295, 1999.
35. Chen ZY and Istfan NW: Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukot Essent Fatty Acids 63, 301-308, 2000.
36. Chen ZY and Istfan NW: Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells. Prostaglandins Leukot Essent Fatty Acids 64, 67-73, 2001.
37. Colquhoun A: Induction of apoptosis by polyunsaturated fatty acids and its relationship to fatty acid inhibition of carnitine palmitoyltransferase I activity in Hep2 cells. Biochem Mol Biol Int 45, 331-336, 1998.
38. Calviello G, et al.: Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis. Int J Cancer 75, 699-675, 1998.
39. Albino AP, et al.: Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Cancer Res 60, 4139-4155, 2000.